Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tempero

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Ear and Hearing|April 30, 2021
Improving the Differential Diagnosis of Otitis Media With Effusion Using Wideband Acoustic ImmittanceGabrielle R Merchant, Sarah Al-Salim, Richard M Tempero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Proliferation and differentiation of CD8+ T cells in the absence of IL-2/15 receptor beta-chain expression or STAT5 activationRyan M Teague, Richard M Tempero, Sunil Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1AM Wettendorff, D Iliopoulos, M Tempero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous hepatic arterial accessM S Copur, M Capadano, J Lynch, et al.
Cancer Research|January 27, 1998
Tolerance and immunity to MUC1 in a human MUC1 transgenic murine modelG J Rowse, R M Tempero, M L VanLith, et al.
International Immunology|July 31, 2002
MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responsesMichelle L VanLith, Karl G Kohlgraf, Connie L Sivinski, et al.
The American Journal of Surgical Pathology|January 1, 1989
Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinomaM Tempero, H Takasaki, E Uchida, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2002
Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccinesConnie L Sivinski, Karl G Kohlgraf, Michelle L VanLith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic miceR M Tempero, M L VanLith, K Morikane, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 18, 2006
Lymphocytopenia in children with lymphatic malformationRichard M Tempero, Mark Hannibal, Laura S Finn, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Ear and Hearing|April 30, 2021
Improving the Differential Diagnosis of Otitis Media With Effusion Using Wideband Acoustic ImmittanceGabrielle R Merchant, Sarah Al-Salim, Richard M Tempero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Proliferation and differentiation of CD8+ T cells in the absence of IL-2/15 receptor beta-chain expression or STAT5 activationRyan M Teague, Richard M Tempero, Sunil Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1AM Wettendorff, D Iliopoulos, M Tempero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous hepatic arterial accessM S Copur, M Capadano, J Lynch, et al.
Cancer Research|January 27, 1998
Tolerance and immunity to MUC1 in a human MUC1 transgenic murine modelG J Rowse, R M Tempero, M L VanLith, et al.
International Immunology|July 31, 2002
MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responsesMichelle L VanLith, Karl G Kohlgraf, Connie L Sivinski, et al.
The American Journal of Surgical Pathology|January 1, 1989
Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinomaM Tempero, H Takasaki, E Uchida, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2002
Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccinesConnie L Sivinski, Karl G Kohlgraf, Michelle L VanLith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic miceR M Tempero, M L VanLith, K Morikane, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 18, 2006
Lymphocytopenia in children with lymphatic malformationRichard M Tempero, Mark Hannibal, Laura S Finn, et al.
Pageof 5